The Liver in Cardiovascular Disease

Textbook of Hepatology: From Basic Science to Clinical Practice, Third Edition

Volumn , Issue , 2008, Pages 1607-1615

  Tiukinhoy Laing, Susan ^a   Blei, Andres T ^a   Gheorghiade, Mihai ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Aminotransferases; Angiotensin; Cardiovascular disease; Centrolobular hepatic necrosis; Ischaemic hepatitis

Indexed keywords

EID: 84889426531     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470691861.ch20a     Document Type: Chapter

References (64)

1. Gheorghiade M, Zannad F, Sopko G et al. (2005) Acute heart failure syndromes: current state and framework for future research. Circulation 112, 3958-3968.
2. Felker GM, Adams KF Jr, Konstam MA et al. (2003) The problem of decompensated heart failure: nomenclature, classification, and risk stratification. Am Heart J 145, S18-S-25.
3. Giallourakis CC, Rosenberg PM, Friedman LS (2002) The liver in heart failure. Clin Liver Dis 6, 947-967.
4. Henrion J, Schapira M, Luwaert R et al. (2003) Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases. Medicine 82, 392-406.
5. Bynum TE, Boitnott JK, Maddrey WC (1979) Ischemic hepatitis. Dig Dis Sci 24, 129-135.
6. Gitlin N, Serio KM (1992) Ischemic hepatitis: widening horizons. Am J Gastroenterol 87, 831-836.
7. Seeto RK, Fenn B, Rockey DC (2000) Ischemic hepatitis: clinical presentation and pathogenesis. Am J Med 109, 109-113.
8. Fuchs S, Bogomolski-Yahalom V, Paltiel O et al. (1998) Ischemic hepatitis: clinical and laboratory observations of 34 patients. J Clin Gastroenterol 26, 183-186.
9. Nouel O, Henrion J, Bernuau J et al. (1980) Fulminant hepatic failure due to transient circulatory failure in patients with chronic heart disease. Dig Dis Sci 25, 49-52.
10. Denis C, Kerguennec C, Bernuau J et al. (2004) Acute hypoxic hepatitis ('liver shock'): still frequently overlooked cardiological diagnosis. Eur J Heart Fail 6, 561-565.
11. Cohen JA, Kaplan MM (1978) Left-sided heart failure presenting as hepatitis. Gastroenterology 74, 583-587.
12. Henrion J, Descamps O, Luwaert R et al. (1994) Hypoxic hepatitis in patients with cardiac failure: incidence in a coronary care unit and measurement of hepatic blood flow. J Hepatol 21, 696-703.
13. Hickman PE, Potter JM (1990) Mortality associated with ischaemic hepatitis. Aust NZ J Med 20, 32-34.
14. Naschitz JE, Slobodin G, Lewis RJ et al. (2000) Heart diseases affecting the liver and liver diseases affecting the heart. Am Heart J 140, 111-120.
15. Bradley SE (1963) The circulation and the liver. Gastroenterology 44, 403-409.
16. Lautt WW, Greenway CV (1987) Conceptual review of the hepatic vascular bed. Hepatology 7, 952-963.
17. Myers JD, Hickam JB (1948) An estimation of the hepatic blood flow and splanchnic oxygen consumption in heart failure. J Clin Invest 27, 620-627.
18. Bailey RW, Brengman ML, Fuh KC et al. (2000) Hemodynamic pathogenesis of ischemic hepatic injury following cardiogenic shock/resuscitation. Shock 14, 451-459.
19. Henrion J, Minette P, Colin L et al. (1999) Hypoxic hepatitis caused by acute exacerbation of chronic respiratory failure: a case-controlled, hemodynamic study of 17 consecutive cases. Hepatology 29, 427-433.
20. Lefkowitch JH, Mendez L (1986) Morphologic features of hepatic injury in cardiac disease and shock. J Hepatol 2, 313-327.
21. Chandel NS, Maltepe E, Goldwasser E et al. (1998) Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci USA 95, 11715-11720.
22. Henrion J (2000) Ischemia/reperfusion injury of the liver: pathophysiologic hypotheses and potential relevance to human hypoxic hepatitis. Acta Gastroenterol Belg 63, 336-347.
23. Biasi F, Chiarpotto E, Lanfrance G et al. (1994) Oxidative stress in the development of human ischemic hepatitis during circulatory shock. Free Radic Biol Med 17, 225-233.
24. Arcidi JM Jr, Moore GW, Hutchins GM (1981) Hepatic morphology in cardiac dysfunction. Am J Pathol 104, 159-166.
25. de la Monte SM, Arcidi JM, Moore GW et al. (1984) Midzonal necrosis as a pattern of hepatocellular injury after shock. Gastroenterology 86, 627-631.
26. Das G, Nussbaum HE, Leff WA (1974) Hepatic function in acute myocardial infarction. JAMA 230, 1558-1560.
27. Szawarski P, Sensky PR, Doshi M et al. (2004) Fulminant liver failure: an indicator of silent myocardial rupture. Postgrad Med J 80, 553-554.
28. Gomez Guindal JA, Roldan Rabadan I, Perea Egido J et al. (1999) Ictericia inducida por estreptocinasa [Streptokinase-induced jaundice]. Rev Esp Cardiol 52, 1025-1027.
29. Pezzi A, Pasetti G, Lombardi F et al. (1999) Liver rupture after cardiopulmonary resuscitation (CPR) and thrombolysis. Intens Care Med 25, 1032.
30. Ziegenfuss MD, Mullany DV (2004) Traumatic liver injury complicating cardio-pulmonary resuscitation. The value of a major intensive care facility: a report of two cases. Crit Care Resusc 6, 102-104.
31. Collins JD, Bassendine MF, Ferner R et al. (1983) Incidence and prognostic importance of jaundice after cardiopulmonary bypass surgery. Lancet 1, 1119-1123.
32. Chu CM, Chang CH, Liaw YF et al. (1984) Jaundice after open heart surgery: a prospective study. Thorax 39, 52-56.
33. Hampton WW, Townsend MC, Schirmer WJ et al. (1989) Effective hepatic blood flow during cardiopulmonary bypass. Arch Surg 124, 458-459.
34. Michalopoulos A, Alivizatos P, Geroulanos S (1997) Hepatic dysfunction following cardiac surgery: determinants and consequences. Hepatogastroenterology 44, 779-783.
35. Jenkins JG, Lynn AM, Wood AE et al. (1982) Acute hepatic failure following cardiac operation in children. J Thorac Cardiovasc Surg 84, 865-871.
36. Narkewicz MR, Sondheimer HM, Ziegler JW et al. (2003) Hepatic dysfunction following the Fontan procedure. J Pediatr Gastroenterol Nutr 36, 352-357.
37. Ghaferi AA, Hutchins GM (2005) Progression of liver pathology in patients undergoing the Fontan procedure: chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. J Thorac Cardiovasc Surg 129, 1348-1352.
38. Arenson DM, Lewis JH, Zimmerman HJ (1984) Post-transfusion hepatitis after cardiac surgery. Br Med J (Clin Res Ed) 288, 403-404.
39. Esteban JI, Gomez J, Martell M et al. (1996) Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med 334, 555-560.
40. Henrion J, Schapira M, Heller FR (1996) Ischemic hepatitis: the need for precise criteria. J Clin Gastroenterol 23, 305-306.
41. White TJ, Leevy CM, Brusca AM et al. (1955) The liver in congestive heart failure. Am Heart J 49, 250-257.
42. Dunn GD, Hayes P, Breen KJ et al. (1973) The liver in congestive heart failure: a review. Am J Med Sci 265, 174-189.
43. Runyon BA (1988) Cardiac ascites: a characterization. J Clin Gastroenterol 10, 410-412.
44. Moussavian SN, Dincsoy HP, Goodman S et al. (1982) Severe hyperbilirubinemia and coma in chronic congestive heart failure. Dig Dis Sci 27, 175-180.
45. Batin P, Wickens M, McEntegart D et al. (1995) The importance of abnormalities of liver function tests in predicting mortality in chronic heart failure. Eur Heart J 16, 1613-1618.
46. Richman SM, Delman AJ, Grob D (1961) Alterations in indices of liver function in congestive heart failure with particular reference to serum enzymes. Am J Med 30, 211-225.
47. Sherlock S (1951) The liver in heart failure: relation of anatomical, functional, and circulatory changes. Br Heart J 13, 273-293.
48. Kubo SH, Walter BA, John DH et al. (1987) Liver function abnormalities in chronic heart failure: Influence of systemic hemodynamics. Arch Intern Med 147, 1227-1230.
49. van Lingen R, Warshow U, Dalton HR et al. (2005) Jaundice as a presentation of heart failure. J R Soc Med 98, 357-359.
50. Wanless IR, Liu JJ, Butany J (1995) Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis). Hepatology 21, 1232-1237.
51. Kanel GC, Ucci AA, Kaplan MM et al. (1980) Distinctive perivenular hepatic lesion associated with heart failure. Am J Clin Pathol 73, 235-239.
52. Moriel M, Morali G, Rosenmann E et al. (2001) Cardioversioninduced fulminant ischaemic hepatitis. Eur J Gastroenterol Hepatol 13, 1481-1483.
53. Sokol SI, Cheng A, Frishman WH et al. (2000) Cardiovascular drug therapy in patients with hepatic diseases and patients with congestive heart failure. J Clin Pharmacol 40, 11-30.
54. Lalka D, Griffith RK, Cronenberger CL (1993) The hepatic first-pass metabolism of problematic drugs. J Clin Pharmacol 33, 657-669.
55. Potter JM, Hickman PE (1992) Cardiodepressant drugs and the high mortality rate associated with ischemic hepatitis. Crit Care Med 20, 474-478.
56. Bravo AE, Drewe J, Schlienger RG et al. (2005) Hepatotoxicity during rapid intravenous loading with amiodarone: description of three cases and review of the literature. Crit Care Med 33, 128-134.
57. Lewis JH, Ranard RC, Caruso A et al. (1989) Amiodarone hepatotoxicity: prevalence and clinicopathologic correlations among 104 patients. Hepatology 9, 679-685.
58. Myers RB, Spodick DH (1999) Constrictive pericarditis: clinical and pathophysiologic characteristics. Am Heart J 138, 219-232.
59. Calleja HB, Rosenow OF, Clark TE (1961) Pulsations of the liver in heart disease. Am J Med 30, 202-210.
60. England RW, Grathwohl KW, Powell GE (2002) Constrictive pericarditis presenting as chylous ascites. J Clin Gastroenterol 35, 104-105.
61. Fred HL (1999) Curable conspicuous ascites: the forgotten four. Hosp Pract (Minn.) 34, 98-100.
62. Cohen CD, Kirsch RE, Saunders SJ et al. (1981) Hepatic sequelae of congestive cardiac failure: evidence for a liver lesion in patients in whom cardiac function had been restored to normal. S Afr Med J 59, 213-216.
63. Estruch R, Fernandez-Sola J, Sacanella E et al. (1995) Relationship between cardiomyopathy and liver disease in chronic alcoholism. Hepatology 22, 532-538.
64. Bohmer T, Kjekshus E, Nitter-Hauge S (1994) Studies on the elimination of bilirubin pre-operatively in patients with mitral valve disease. Eur Heart J 15, 10-16.